Target intelligence / Profile preview

Vascular capacitance vessel (null)

Target
null
Molecular classification
Other
01

Overview

Vascular capacitance vessels refer to blood vessels—primarily veins and venules—that can distribute and store large volumes of blood with minimal changes in pressure, acting as a blood reservoir[1][3][6]. About 60–70% of total blood volume is sequestered in these vessels at rest[1][6]. They are highly compliant (distensible) and play a critical role in regulating cardiac preload, venous return, and arterial blood pressure by controlling how much blood is shifted between the peripheral venous system (capacitance vessels) and the central circulation[1][3][5]. Pharmacologic intervention on capacitance vessels is a foundational strategy in the management of conditions such as heart failure and hypertension, but the vessels themselves are not single molecular targets, receptors, or enzymes—they represent an anatomical and functional classification of the venous system[1][3][6][5][9]. Note: "Vascular capacitance vessels" is a physiological concept and vessel classification, not a molecule or drug target. Thus, it is not appropriate to treat it as a canonical molecular target; this term is most useful in cardiovascular physiology and clinical medicine when considering the hemodynamic properties of veins and related blood reservoirs[6][1][3][5].

Other names
Capacitance vesselVenous capacitance vesselVein (in this context)Venous system
02

Mechanism of action

- Venodilation (increasing capacitance, lowering preload and venous return; e.g., nitrates) - Venoconstriction (decreasing capacitance, increasing venous return; e.g., alpha-adrenergic agonists)

03

Biological functions

Blood reservoirRegulation of blood volumeRegulation of blood pressureVenous return
04

Disease associations

Cardiovascular diseaseHeart failureHypertensionOrthostatic hypotensionVaricose veins
05

Safety considerations

Risk of orthostatic hypotensionPeripheral edema with excessive venodilationPotential for worsening heart failure if venous return is excessively altered
06

Interacting drugs

Nitrates (e.g., nitroglycerin)

3 more in the full profile.

Beyond the preview

Go deeper on Vascular capacitance vessel (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular capacitance vessel (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call